IMAX vs Cineplex Which Is More Attractive?

IMAX Corporation and Cineplex Inc. are two prominent players in the entertainment industry, with a focus on providing immersive movie-watching experiences. While IMAX is known for its large-format theaters and cutting-edge technology, Cineplex operates a network of traditional movie theaters across North America. Both companies have seen fluctuations in their stock prices due to various factors such as shifting consumer preferences, competition from streaming services, and the impact of the COVID-19 pandemic on the film industry. Investors looking to capitalize on the movie-going experience may find opportunities in both IMAX and Cineplex stocks, but careful consideration of market trends and financial performance is essential for making informed investment decisions.

IMAX

Cineplex

Stock Price
Day Low$25.57
Day High$26.30
Year Low$13.20
Year High$26.84
Yearly Change103.33%
Revenue
Revenue Per Share$6.56
5 Year Revenue Growth0.16%
10 Year Revenue Growth0.61%
Profit
Gross Profit Margin0.53%
Operating Profit Margin0.12%
Net Profit Margin0.07%
Stock Price
Day Low$8.85
Day High$9.03
Year Low$5.21
Year High$9.19
Yearly Change76.39%
Revenue
Revenue Per Share$17.74
5 Year Revenue Growth-0.29%
10 Year Revenue Growth-0.03%
Profit
Gross Profit Margin0.58%
Operating Profit Margin0.04%
Net Profit Margin-0.04%

IMAX

Cineplex

Financial Ratios
P/E ratio58.87
PEG ratio2.20
P/B ratio4.74
ROE8.56%
Payout ratio0.00%
Current ratio1.51
Quick ratio1.39
Cash ratio0.34
Dividend
Dividend Yield-%
5 Year Dividend Yield0.00%
10 Year Dividend Yield0.00%
IMAX Dividend History
Financial Ratios
P/E ratio-16.37
PEG ratio-0.12
P/B ratio-20.59
ROE229.04%
Payout ratio0.00%
Current ratio0.30
Quick ratio0.26
Cash ratio0.07
Dividend
Dividend Yield-%
5 Year Dividend Yield0.00%
10 Year Dividend Yield0.00%
Cineplex Dividend History

IMAX or Cineplex?

When comparing IMAX and Cineplex, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between IMAX and Cineplex.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. IMAX has a dividend yield of -%, while Cineplex has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. IMAX reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Cineplex reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with IMAX P/E ratio at 58.87 and Cineplex's P/E ratio at -16.37. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. IMAX P/B ratio is 4.74 while Cineplex's P/B ratio is -20.59.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, IMAX has seen a 5-year revenue growth of 0.16%, while Cineplex's is -0.29%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with IMAX's ROE at 8.56% and Cineplex's ROE at 229.04%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $25.57 for IMAX and $8.85 for Cineplex. Over the past year, IMAX's prices ranged from $13.20 to $26.84, with a yearly change of 103.33%. Cineplex's prices fluctuated between $5.21 and $9.19, with a yearly change of 76.39%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.

Comparision